Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial-Reference-Cited by-同舟云学术

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial

Published:2021-12 Issue: Volume: Page:
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Sutharsan Sivagurunathan,McKone Edward F,Downey Damian G,Duckers Jamie,MacGregor Gordon,Tullis Elizabeth,Van Braeckel Eva,Wainwright Claire E,Watson Danie,Ahluwalia Neil,Bruinsma Bote G,Harris Christopher,Lam Anna P,Lou Yiyue,Moskowitz Samuel M,Tian Simon,Yuan Jason,Waltz David,Mall Marcus A,Aurora Paul,Verhulst Stijn,Watson Danie,Lorenz Michael,Roehmel Jobst,Gleiber Wolfgang,Naehrig Susanne,Stehling Florian,Sutharsan Sivagurunathan,van Koningsbruggen-Rietschel Silke,Fischer Rainald,Downey Damian,Haworth Charles,Duckers Jamie,Legg Julian,Barry Peter,Thursfield Rebecca,Doe Simon James,Hilliard Tom,MacGregor Gordon,Nash Edward F,Withers Nicholas John,Peckham Daniel,Barr Helen Louise,Lee Timothy,Gray Robert,Vermeulen Francois,Van Braeckel Eva,Vanderhelst Eef,Robinson Philip J,Wainwright Claire E,Smith Daniel J,Mulrennan Siobhain A,Clements Barry S,Wark Peter

Funder

Vertex Pharmaceuticals Incorporated

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference29 articles.

1. Cystic fibrosis;O'Sullivan;Lancet,2009

2. Cystic fibrosis;Elborn;Lancet,2016

3. The future of cystic fibrosis care: a global perspective;Bell;Lancet Respir Med,2020

4. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity;Anderson;Science,1991

5. Cystic fibrosis;Ratjen;Nat Rev Dis Primers,2015

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic Fibrosis: A Journey through Time and Hope;International Journal of Molecular Sciences;2024-09-04

2. Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis;APMIS;2024-08-02

3. Elexacaftor/Tezacaftor/Ivacaftor Effectiveness in N1303K Variant in Adult People With Cystic Fibrosis;Archivos de Bronconeumología;2024-08

4. EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference;European Respiratory Review;2024-07

5. Pathophysiology and genomics of bronchiectasis;European Respiratory Review;2024-07